Value of fluorodeoxyglucose PET/computed tomography patient management and outcomes in thyroid cancer

Anthony Ciarallo, Charles Marcus, Mehdi Taghipour, Rathan M. Subramaniam

Research output: Contribution to journalArticle

Abstract

"Fluorodeoxyglucose (FDG) PET/computed tomography (CT) is used most frequently in the surveillance of iodine-refractory differentiated thyroid cancer with increased thyroglobulin level after therapy. This article evaluates the impact of FDG-PET/CT on clinical management and the prognostic implications of a positive scan. In the studies reviewed, FDG-PET/CT changed the course of management in 14% to 78% of patients with suspected recurrence, and a positive scan was associated with poorer survival. Similar conclusions are supported in the literature for anaplastic and medullary thyroid cancers, although these are based on fewer studies on account of the lower prevalence of these subtypes."

Original languageEnglish (US)
Pages (from-to)265-278
Number of pages14
JournalPET Clinics
Volume10
Issue number2
DOIs
StatePublished - Apr 1 2015

Fingerprint

Thyroid Neoplasms
tomography
cancer
Tomography
Thyroglobulin
refractories
surveillance
Iodine
iodine
therapy
Recurrence
Survival
Therapeutics

Keywords

  • FDG
  • Outcome
  • PET/CT
  • Prognosis
  • Thyroid cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Medicine(all)

Cite this

Value of fluorodeoxyglucose PET/computed tomography patient management and outcomes in thyroid cancer. / Ciarallo, Anthony; Marcus, Charles; Taghipour, Mehdi; Subramaniam, Rathan M.

In: PET Clinics, Vol. 10, No. 2, 01.04.2015, p. 265-278.

Research output: Contribution to journalArticle

Ciarallo, Anthony ; Marcus, Charles ; Taghipour, Mehdi ; Subramaniam, Rathan M. / Value of fluorodeoxyglucose PET/computed tomography patient management and outcomes in thyroid cancer. In: PET Clinics. 2015 ; Vol. 10, No. 2. pp. 265-278.
@article{6d6a3f4323834e55a77e9e6fed35c78d,
title = "Value of fluorodeoxyglucose PET/computed tomography patient management and outcomes in thyroid cancer",
abstract = "{"}Fluorodeoxyglucose (FDG) PET/computed tomography (CT) is used most frequently in the surveillance of iodine-refractory differentiated thyroid cancer with increased thyroglobulin level after therapy. This article evaluates the impact of FDG-PET/CT on clinical management and the prognostic implications of a positive scan. In the studies reviewed, FDG-PET/CT changed the course of management in 14{\%} to 78{\%} of patients with suspected recurrence, and a positive scan was associated with poorer survival. Similar conclusions are supported in the literature for anaplastic and medullary thyroid cancers, although these are based on fewer studies on account of the lower prevalence of these subtypes.{"}",
keywords = "FDG, Outcome, PET/CT, Prognosis, Thyroid cancer",
author = "Anthony Ciarallo and Charles Marcus and Mehdi Taghipour and Subramaniam, {Rathan M.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.cpet.2014.12.009",
language = "English (US)",
volume = "10",
pages = "265--278",
journal = "PET Clinics",
issn = "1556-8598",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Value of fluorodeoxyglucose PET/computed tomography patient management and outcomes in thyroid cancer

AU - Ciarallo, Anthony

AU - Marcus, Charles

AU - Taghipour, Mehdi

AU - Subramaniam, Rathan M.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - "Fluorodeoxyglucose (FDG) PET/computed tomography (CT) is used most frequently in the surveillance of iodine-refractory differentiated thyroid cancer with increased thyroglobulin level after therapy. This article evaluates the impact of FDG-PET/CT on clinical management and the prognostic implications of a positive scan. In the studies reviewed, FDG-PET/CT changed the course of management in 14% to 78% of patients with suspected recurrence, and a positive scan was associated with poorer survival. Similar conclusions are supported in the literature for anaplastic and medullary thyroid cancers, although these are based on fewer studies on account of the lower prevalence of these subtypes."

AB - "Fluorodeoxyglucose (FDG) PET/computed tomography (CT) is used most frequently in the surveillance of iodine-refractory differentiated thyroid cancer with increased thyroglobulin level after therapy. This article evaluates the impact of FDG-PET/CT on clinical management and the prognostic implications of a positive scan. In the studies reviewed, FDG-PET/CT changed the course of management in 14% to 78% of patients with suspected recurrence, and a positive scan was associated with poorer survival. Similar conclusions are supported in the literature for anaplastic and medullary thyroid cancers, although these are based on fewer studies on account of the lower prevalence of these subtypes."

KW - FDG

KW - Outcome

KW - PET/CT

KW - Prognosis

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=84926216874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926216874&partnerID=8YFLogxK

U2 - 10.1016/j.cpet.2014.12.009

DO - 10.1016/j.cpet.2014.12.009

M3 - Article

C2 - 25829091

AN - SCOPUS:84926216874

VL - 10

SP - 265

EP - 278

JO - PET Clinics

JF - PET Clinics

SN - 1556-8598

IS - 2

ER -